Source:http://linkedlifedata.com/resource/pubmed/id/20416158
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0013089,
umls-concept:C0017262,
umls-concept:C0162638,
umls-concept:C0185117,
umls-concept:C0205263,
umls-concept:C0219474,
umls-concept:C0242643,
umls-concept:C0246415,
umls-concept:C0376515,
umls-concept:C0449207,
umls-concept:C0559546,
umls-concept:C1512310,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-4-26
|
pubmed:abstractText |
This study was aimed to investigate the effect of Docetaxel on drug-resistant leukemia cell line HL-60/ADR and its influence on expression of P-pg, BCL-2 and BAX proteins so as to provide a new strategy and theoretical basis for clinical solution of leukemia drug-resistance. The morphological changes of HL-60/ADR were observed by light and transmission electron microscopes; the cell apoptosis was detected by flow cytometry with Annexin V FITC/PI double labeling; the expressions of P-gp, BCL-2 and BAX were determined by immunohistochemical technique and computer image analysis system. The results showed that the HL-60/ADR cells treated with Docetaxel displayed typical apoptotic morphological changes; the Docetaxel significantly inhibited the growth of HL-60/ADR cells in concentration-and time-dependent manners (r=0.853, r=0.989) and induced the apoptosis of HL-60/ADR cells, but apoptosis rate did not showed the increase trend along with concentration change of drug. The HL-60/ADR cells highly expressed P-gp, there were no significant differences between each groups; the expression of BCL-2 and BAX in HL-60/ADR cells decreased and increased respectively. It is concluded that the Docetaxel induces apoptosis of HL-60/ADR cells, decreases the expression of BCL-2 protein and increases the expression of BAX protein.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABCB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1009-2137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-6
|
pubmed:meshHeading |
pubmed-meshheading:20416158-Apoptosis,
pubmed-meshheading:20416158-HL-60 Cells,
pubmed-meshheading:20416158-Humans,
pubmed-meshheading:20416158-P-Glycoprotein,
pubmed-meshheading:20416158-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:20416158-Taxoids,
pubmed-meshheading:20416158-bcl-2-Associated X Protein
|
pubmed:year |
2010
|
pubmed:articleTitle |
[Docetaxel induces apoptosis and influences the expression of P-gp, BCL-2 and BAX protein in HL-60/ADR cells].
|
pubmed:affiliation |
Department of Hematology, The First Hospital, Xi'an Jiaotong University Medical College, Xi'an 710061, Shaanxi Province, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|